Hoag Memorial Hospital Presbyterian recently announced encouraging clinical study results for patient-specific vaccine therapy to treat metastatic melanoma. The study is ongoing, but the report concludes that patient-specific vaccines can sometimes induce durable complete regression of progressing soft-tissue melanoma metastases, as demonstrated in one particular patient who participated in the trial.
Science Brief thanks to EurekAlert.
Read more here:
Study shows patient-specific vaccines for metastatic melanoma may induce durable complete regression
Net News Publisher for Science News
Related articles by Zemanta
- Promising Treatment for Metastatic Melanoma ‘fast Tracked’ By FDA (netnewspublisher.com)
- ‘Co-conspirator’ Cells Could Hold Key to Melanoma Prediction, Prevention (netnewspublisher.com)
- Imaging Melanoma (netnewspublisher.com)
